Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

BST2 protein and certain T cells increase in early alopecia areata.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Scalp rolling might help regrow hair in people with a hair loss condition called Alopecia Areata.

Lavender, lemongrass, rosemary, and chamomile essential oils may help protect cells important for hair growth from damage and could promote hair growth.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

Microneedles could be a better and easier way to regrow hair.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

PRC1 is essential for proper skin development and stem cell formation by controlling gene activity.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Cyclosporine may cause hair loss, so patients need monitoring.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Non-drug therapies show promise for hair regrowth but need more research.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.